Recent Finacing
Recent Raise
Nine Square Therapeutics develops small-molecule therapeutics for movement disorders (Parkinson’s, ALS, essential tremor, dyskinesias) using computational chemistry, biophysics, computational biology and ML-enabled cell profiling for target identification and optimization.
